Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Immunome Inc., 2 years.
Immunome Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunome Inc. June 10, 202575.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Immunome Inc. | Open-market sale | −11,048 | $27.25 | $301,058 |
| Aug 11, 2026 | Immunome Inc. | Open-market sale | −62,291 | $26.23 | $1,633,893 |
| Aug 10, 2026 | Immunome Inc. | Open-market sale | −10,125 | $26.07 | $263,959 |
| Aug 7, 2026 | Immunome Inc. | Open-market sale | −15,248 | $26.06 | $397,363 |
| Aug 6, 2026 | Immunome Inc. | Open-market sale | −20,840 | $26.06 | $543,090 |
| Jul 7, 2026 | Immunome Inc. | Open-market sale | −16,906 | $24.20 | $409,125 |
| Jul 6, 2026 | Immunome Inc. | Open-market sale | −83,094 | $24.11 | $2,003,396 |
| Jul 2, 2026 | Immunome Inc. | Open-market sale | −75,665 | $22.35 | $1,691,113 |
| Jul 2, 2026 | Immunome Inc. | Open-market sale | −24,335 | $23.33 | $567,736 |
| Jun 30, 2026 | Immunome Inc. | Open-market sale | −101,050 | $21.12 | $2,134,176 |
| Dec 22, 2025 | Immunome Inc. | Open-market sale | −371,949 | $21.72 | $8,078,732 |
| Dec 22, 2025 | Immunome Inc. | Open-market sale | −11,251 | $22.34 | $251,347 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.